These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37705461)

  • 1. Inflammatory innate lymphoid cells predict response speed to dupilumab in chronic rhinosinusitis with nasal polyps.
    Golebski K; van der Lans RJL; van Egmond D; de Groot E; Spits H; der Zee AM; van Drunen CM; Fokkens WJ; Reitsma S
    Allergy; 2023 Dec; 78(12):3265-3268. PubMed ID: 37705461
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous Dupilumab and Mometasone Furoate Nasal Spray for Chronic Rhinosinusitis With Polyps.
    Schneider JS
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):698-9. PubMed ID: 27258602
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab in pediatric severe chronic rhinosinusitis with nasal polyps and asthma.
    Bragança M; Pereira AM; Plácido JL; Amaral L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2024 Jan; 141(1):55-56. PubMed ID: 37591762
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.
    van der Lans RJL; Fokkens WJ; Adriaensen GFJPM; Hoven DR; Drubbel JJ; Reitsma S
    Allergy; 2022 Feb; 77(2):670-674. PubMed ID: 34626497
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic pulmonary complications of dupilumab in 2 patients with asthma and chronic rhinosinusitis with nasal polyps.
    Frohlich M; Olivenstein R; Cormier M
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):617-619. PubMed ID: 34929373
    [No Abstract]   [Full Text] [Related]  

  • 8. Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP).
    Lepley TJ; Wu Z; Root Z; Mountain D; Otto BA; Kelly K; Zhao K
    Int Forum Allergy Rhinol; 2022 Dec; 12(12):1578-1580. PubMed ID: 35765860
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials.
    Peters AT; Soler ZM; Kern RC; Heffler E; Maspero JF; Crampette L; Fujieda S; Lane AP; Zhang H; Nash S; Khan AH; Siddiqui S; Jacob-Nara JA; Rowe P; Deniz Y
    Clin Exp Allergy; 2022 Sep; 52(9):1105-1109. PubMed ID: 35775319
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepolizumab for chronic rhinosinusitis with nasal polyps.
    Brusselle GG; Gevaert P
    Lancet Respir Med; 2021 Oct; 9(10):1081-1082. PubMed ID: 33872589
    [No Abstract]   [Full Text] [Related]  

  • 13. Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studies.
    Bachert C; Peters AT; Heffler E; Han JK; Olze H; Pfaar O; Chuang CC; Rout R; Attre R; Goga L; Jacob-Nara JA; Rowe PJ; Deniz Y; Chen Z; Kamat S; Siddiqui S
    Clin Exp Allergy; 2022 Feb; 52(2):244-249. PubMed ID: 35092110
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis.
    Fokkens W; Van Der Lans R; Reitsma S
    Expert Opin Biol Ther; 2021 May; 21(5):575-585. PubMed ID: 33724109
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
    Boiko NV; Stagnieva IV; Lodochkina OE; Kurbatova NV
    Vestn Otorinolaringol; 2023; 88(4):46-53. PubMed ID: 37767590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do preoperative corticosteroids benefit patients with chronic rhinosinusitis with nasal polyposis?
    Carlton DA; Chiu AG
    Laryngoscope; 2019 Apr; 129(4):773-774. PubMed ID: 30408190
    [No Abstract]   [Full Text] [Related]  

  • 17. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis.
    Aschenbrenner DS
    Am J Nurs; 2019 Oct; 119(10):21-22. PubMed ID: 31567245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.